The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.

Kihealth’s diabetes assay, which measures the earliest biomarker of insulin resistance, is claimed to be the first diagnostic of its kind.

Wearable devices and biometric tracking can alert clinicians to early warning signs conditions, allowing interventions before hospitalisation becomes necessary ...

The lateral flow assay market is poised for growth via increasing home-based self-testing kits, integration with smartphones for telehealth, and expansions in food safety and environmental monitoring.

A man with type 1 diabetes produces his own insulin after receiving genetically-modified donor islet cells, without the need for medication.

The Center for Life Science Venturers (CLSV) has admitted a promising biotech startup company with deep roots at Cornell. Persista Bio is pushing toward a goal that has tantalized scientists for ...

TALLAHASSEE, Fla. — From fentanyl testing for suspected overdose patients and regulations for surrendered infants, to diabetes management in schools and liability for property damage in a hit-and-run, ...

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations.

Analysts have set 12-month price targets for Abbott Laboratories, revealing an average target of $143.25, a high estimate of $155.00, and a low estimate of $135.00. This current average reflects an ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we might recover from our next cold. I got my results in a text message.

Intricon and Minnetronix Medical have merged to form Forj Medical, a new medtech contract development and manufacturing organization (CDMO).